Next Article in Journal
Cancer Nutrition and Rehabilitation—Its Time Has Come!
Previous Article in Journal
Malignant Mesothelioma: Canadian Perspective and Research Directions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 15
Issue 2
10.3747/co.v15i2.263
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success

by
Kara Laing
Medical Oncologist Cancer Care Program Associate Professor Memorial University of NL
Curr. Oncol. 2008, 15(2), 112-113; https://doi.org/10.3747/co.v15i2.263
Submission received: 3 January 2008 / Revised: 4 February 2008 / Accepted: 5 March 2008 / Published: 1 April 2008

Abstract

A 52-year-old postmenopausal woman presented with an abnormal screening mammogram showing a suspicious area in the upper outer quadrant of her left breast. [...]

Share and Cite

MDPI and ACS Style

Laing, K. Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success. Curr. Oncol. 2008, 15, 112-113. https://doi.org/10.3747/co.v15i2.263

AMA Style

Laing K. Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success. Current Oncology. 2008; 15(2):112-113. https://doi.org/10.3747/co.v15i2.263

Chicago/Turabian Style

Laing, Kara. 2008. "Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success" Current Oncology 15, no. 2: 112-113. https://doi.org/10.3747/co.v15i2.263

APA Style

Laing, K. (2008). Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success. Current Oncology, 15(2), 112-113. https://doi.org/10.3747/co.v15i2.263

Article Metrics

Back to TopTop